Biopharma Stocks Rally; CanSino, Zhongguancun Hit Daily Limit

In early trading on August 26, the biopharmaceutical sector showed strong activity, with CanSino Biologics and Zhongguancun hitting the daily limit, and Weiguang Biologics rising for a second consecutive trading day. Tebao Bio, Walvax Biotechnology, Wantai Bio, Zhifei Biologics, Anke Bio, Baike Bio, and Ganlee Pharma were among the stocks with notable gains.

Vaccine-related concepts also strengthened in tandem, with CanSino Biologics and Weiguang Biologics hitting the daily limit, while Walvax Biotechnology, Zhifei Biologics, Kangtai Bio, and Kanghua Bio posted notable gains.